Effect of COVID-19 on Mortality of Pregnant and Postpartum Women: A Systematic Review and Meta-Analysis

Karimi, Leila; Makvandi, Somayeh; Vahedian-Azimi, Amir; Sathyapalan, Thozhukat; Sahebkar, Amirhossein

doi:https://doi.org/10.1155/2021/8870129

Journal of Pregnancy

On this page

Abstract Introduction Methods Results Discussion Conclusion Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Review Article | Open Access

Volume 2021 | Article ID 8870129 | https://doi.org/10.1155/2021/8870129

Effect of COVID-19 on Mortality of Pregnant and Postpartum Women: A Systematic Review and Meta-Analysis

Leila Karimi,¹Somayeh Makvandi,²Amir Vahedian-Azimi,³Thozhukat Sathyapalan,⁴and Amirhossein Sahebkar^5,6,7

Academic Editor: Olav Lapaire

Received26 Sept 2020

Revised12 Jan 2021

Accepted11 Feb 2021

Published08 Mar 2021

Abstract

Background. Based on what is known at this time, pregnant women are at an increased risk of severe illness from COVID-19 compared to nonpregnant women. Additionally, pregnant women with COVID-19 might have an increased risk of adverse pregnancy outcomes. To investigate the effects of coronavirus disease 2019 (COVID-19) on mortality of pregnant and postpartum women, we performed a systematic review of available published literature on pregnancies affected by COVID-19. Methods. Web of Science, SCOPUS, and MEDLINE- databases were searched for original studies concerning the effect of COVID-19 on mortality of pregnant and postpartum women published by July 10, 2020. Meta-analyses of proportions were used to combine data and report pooled proportions. Results. 117 studies with a total of 11758 pregnant women were included. The age ranged between 15 and 48 years. Most subjects were infected with SARS-CoV-2 in the third trimester. Disease severity was not reported in 1125 subjects. Maternal mortality was 1.3%. In 100% of fatal cases with adequate data, fever alone or with cough was one of the presenting symptoms. Also, dyspnea (58.3%) and myalgia (50%) were the most common symptoms. Sore throat (8.3%) and gastrointestinal symptoms (anorexia, nausea) (8.3%) were rare. The rate of comorbidities was 20% among COVID-19 deaths. The majority of COVID-19-infected women who died had cesarean section (58.3%), 25% had a vaginal delivery, and 16.7% of patients were not full term. Conclusion. COVID-19 infection in pregnant women was associated with higher rates (and pooled proportions) of cesarean section and mortality. Because new data are continuously being generated and published, the findings of this study can be complete and updated with new researches. The results of this study can guide and improve prenatal counseling of COVID-19-infected pregnant women.

1. Introduction

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global public health crisis [1, 2]. The impact of COVID-19 on specific populations, including pregnant women and their newborns, remains mostly unknown and unstudied. There is not sufficient information about the effect of this disease in pregnant women, and most available studies have evaluated the impact of the disease in the general population. Pregnant women are at a higher risk for acquiring viral respiratory infections and severe pneumonia due to physiological changes in their immune and cardiopulmonary systems [1–3].

The observed outcomes have been different from what was seen during the H1N1 pandemic and with influenza outbreaks, all of which resulted in increased mortality in women who were pregnant [4]. Studies in pregnant women during coronavirus outbreaks (SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV) show that pregnant women are susceptible to experiencing adverse events such as requiring hospitalization or intensive care unit (ICU) admission, endotracheal intubation, and renal failure [5–7].

Worldwide, there are more than 140 million births every year, and pregnant women are potentially at risk for adverse outcomes of novel coronavirus. Although maternal mortality has been reported in some studies, limited information is available about SARS-CoV-2 infection in critically ill pregnant women hospitalized for COVID-19 [8, 9]. Also, there is a multitude of case reports of infection with SARS-CoV-2 during pregnancy but their small sample size makes it difficult to properly find potential complications [10, 11].

The findings of a study on 8207 SARS-CoV-2-infected pregnant women showed an increased risk for ICU admission and mechanical ventilation compared with nonpregnant women; however, the risk for death was similar [12]. Also, the Centers for Disease Control and Prevention surveillance report from the United States noted that pregnant women were more likely to be admitted to the ICU and receive mechanical ventilation than nonpregnant women. However, after adjusting for age, presence of underlying medical conditions, and race/ethnicity, mortality rate was not increased [12].

Based on data from the early stage of pandemic, it is reassuring that there are low rates of maternal mortality with SARS-CoV-2 [13]. However, more studies are needed to learn more about maternal mortality. This study is aimed at performing a systematic review of available published literature on pregnancies affected by COVID-19 to evaluate the effect of COVID-19 on mortality of pregnant and postpartum women.

2. Methods

2.1. Study Design

This study is a systematic scoping review based on the methodological framework of Arksey and O’Malley [14]. Five stages of the framework they adopted for conducting a scoping study are as follows: (1) identifying the research question, (2) identifying relevant studies, (3) study selection, (4) charting the data, and (5) collating, summarizing, and reporting the results.

2.2. Research Questions

The main questions of the study included the following. What is the mortality rate of COVID-19 in pregnant and postpartum women, and how many and what type of comorbidities were found in recovered and deceased patients? What were the disease symptoms and the mode of delivery in the maternal deaths?

2.3. Search Strategy and Eligibility Criteria

We searched scientific databases of Web of Science, SCOPUS, and MEDLINE through the interface, for original studies concerning the effect of COVID-19 on maternal death published until July 10, 2020. We designed a comprehensive optimal search strategy consisted of two components related to pregnancy and COVID-19. The complete search strategy is shown in Table 1. Also, the Google Scholar engine was searched for potentially relevant articles. Eligible studies for inclusion in this systematic review were those that met all of the following criteria: (i) the analysis was performed in pregnant and postpartum women affected by COVID-19 (laboratory confirmed and/or clinically diagnosed) and (ii) the study was a full paper with original data and (iii) was written in English. Studies were excluded if they did not provide sufficient information about the patient outcome (survival or death and important related details).

2.4. Study Selection

After removing the duplicates, the search output was screened as the first step. The titles and abstracts of the articles were screened by the two authors independently according to the eligibility criteria. Then, in the secondary screening, the full texts of the retrieved articles were reviewed by the same authors. Disagreements were resolved through discussion and consensus.

2.5. Data Extraction

A data collection form was designed by the authors to extract the data of the papers in an integrated way. Characteristics of the studies were extracted, including details of the first author’s name, country, sample size, age, gestational age, comorbidities and complications in pregnancy, severity of COVID-19, ICU admission and ventilation need, complications during treatment of COVID-19, and maternal mortality rate. In deceased patients, more information was extracted, including presenting symptoms, mode of delivery, duration of admission to death, and the result of the polymerase chain reaction (PCR) testing of the neonates. Data extraction was performed by two authors independently, and any disagreements were resolved through discussion and team consensus.

2.6. Statistical Analysis

All analyses were conducted by STATA16 (StataCorp, College Station, Texas, USA). The study statistician performed data extraction for primary outcomes. Random effect meta-analyses were applied using restricted maximum likelihood method [15]. The random effect model was used because there may be other unknown, unregistered/unpublished studies to which we could not have access. The between-study heterogeneity was evaluated using the Cochran test and Tau-squared, -squared, and -squared statistics. Significance results of the test and values higher than 75% for -squared were considered as substantial heterogeneity while a value of -squared = 1 indicates perfect homogeneity among the studies [16, 17]. The common effect sizes were calculated as the proportion and rate for binary and count outcomes, respectively, and their 95% confidence intervals (CIs). To assess the publication bias, the funnel plots were drawn. Additionally, Egger’s [18] and Begg’s [19] tests were conducted. A nonparametric “trim and fill” method of accounting for publication bias was performed and showed that there is no need for a modified effect size [20]. Finally, there were studies that have just one sample in some outcomes that conducted a sensitivity analysis by removing the studies with sample.

2.7. Ethical Considerations

The present study complies with all the recommended principles of research ethics. The official approval of the Research Ethics Committee was not obtained for this study because it was a review of the findings of other previously published papers that were available to the public. To comply with the ethical principles, the authors did their best to avoid plagiarism and refused to manipulate the data for personal interests. Respect for the rights of other authors was provided by citing them in the text of the study when information belonging to them was expressed.

3. Results

3.1. Search Results

Figure 1 shows the PRISMA flow chart for study selection. The search strategy retrieved 1348 records and 4 additional records identified through Google Scholar search. After removing 632 duplicates, 720 titles and abstracts were screened. In the second screening, 167 full texts were evaluated and a total of 117 studies were included in the systematic review.

3.2. General Characteristics

The characteristics of the included studies are shown in Table 2. A total of 11758 pregnant women entered the review study ranging from 1 to 8207 per study. The age range of patients was between 15 and 48 years. Most subjects were infected with SARS-CoV-2 in the third trimester. Disease severity was not reported in 1125 samples. In the remaining cases, the highest frequency was related to asymptomatic COVID-19 (, 51.4%).

In terms of the country of origin, the highest frequencies were in China with 34 articles [8, 12, 21–52], the United States with 33 articles [5, 8, 12, 22–51], and Italy with 8 articles [52–59]. 65 studies including 10183 patients were undertaken in the high-income countries [5, 8, 12, 22–83] and 52 studies () in middle-income countries [21, 84–134].

3.3. Outcomes

3.3.1. Mortality Rate of Pregnant and Postpartum Women due to COVID-19

In total, there were 153 deaths out of 11758 pregnant and postpartum women affected by COVID-19 (1.30%), of which 19 deceased patients were in high-income countries including the United Kingdom, United States, Italy, Switzerland, France, Sweden, Portugal, Netherlands, Ireland, Spain, Canada, and Australia () and 134 women were in middle-income countries including China, Iran, Iraq, Jordan, Peru, Turkey, India, Venezuela, Thailand, Brazil, and Honduras ().

The data on 136 cases of maternal death due to COVID-19 is presented in Table 3. The highest mortality rate was reported in the study of Takemoto et al. in Brazil using the Brazilian Ministry of Health’s ARDS Surveillance System. In this study, the authors found 124 deaths in COVID-19-infected pregnant or postpartum women (12.7%) [131].

3.3.2. Presenting Symptoms of COVID-19 in Pregnant and Postpartum Women Who Died of COVID-19

In all of the fatal cases with adequate data, fever alone or with cough was one of the presenting symptoms. After them, dyspnea (58.3%) and myalgia (50%) were the most common symptoms, respectively. Sore throat (8.3%) and gastrointestinal symptoms (anorexia, nausea) (8.3%) were rare.

3.3.3. Comorbidity Rate in Pregnant and Postpartum Women Who Died of COVID-19

The comorbidity rate in women who died from COVID-19 was 20% (Table 3). In total, 41.7% of the deceased patients were 35 years or older (advanced maternal age), 31.1% had diabetes, 21.9% were obese, 14.1% had cardiovascular disease (essential hypertension, gestational hypertension, preeclampsia, HELLP syndrome, and heart problems), and 9.1% had a history of asthma.

3.3.4. Meta-Analysis Results for Morbidities in Patients Who Died of COVID-19

The effect size in five studies for obesity was 0.47 (95% CI: 0.04 to 0.90, value = 0.03), for diabetes was 0.29 (95% CI: -0.08 to 0.65, value = 0.12), for asthma was 0.41 (95% CI: -0.06 to 0.88, value = 0.09), for cardiovascular disease was 0.03 (95% CI: -0.03 to 0.10, value = 0.32), for advanced maternal age was 0.61 (95% CI: 0.13 to 1.08, value = 0.01), and for all comorbidity rate was 14.02 (95% CI: -7.59 to 35.63, value = 0.20), based on a random effect model, with significant heterogeneity between studies ( or about 100.0%, and for all effect sizes). Figure 2 shows the forest plot of individual effect sizes within each study. Assessment for bias by Egger’s and Begg’s tests showed no significant small-study effects (all ). Further visual inspection of the funnel plot suggested a slight degree of publication bias (Figure 3).

3.3.5. Meta-Analysis Results for Obesity

(1) Obesity in All Pregnant and Postpartum Women Affected by COVID-19. The proportion from 33 studies was 0.69 (95% CI: 0.56 to 0.82, value < 0.001) based on a random effect model, with significant heterogeneity between studies (, , , , ). Figure 4 shows the forest plot of individual effect sizes within each study. Assessment for bias by Egger’s and Begg’s tests showed no significant small-study effects ( and , respectively). Further visual inspection of the funnel plot suggests a slight degree of publication bias (Figure 5).

(2) Sensitivity Analysis after Deleting the Studies with n=1. Removing these studies resulted in an effect size (95% CI: 0.33 to 0.66, value < 0.001), with a significant heterogeneity (, , , , ). Figure 6 shows the forest plot of individual effect sizes within each study.

(3) Subgroup Analysis of Obesity in Recovered and Dead Pregnant and Postpartum Women. The forest plot of the individual effect size of predetermined subgroup analysis by dead/recovered is presented in Figure 7. The results indicate higher proportion of outcome in the recovered subgroup (, to 0.71), than in the deceased subgroup (, to 0.25). Therefore, the test showed a significant difference between the subgroups (, ). Additionally, the heterogeneity did not reduce in all subgroups ( and in the recovered and deceased subgroups, respectively).

3.3.6. Meta-Analysis Results for Diabetes (Pregestational or Gestational)

(1) Diabetes in All Pregnant and Postpartum Women Affected by COVID-19. The proportion from 38 studies was 0.38 (95% CI: 0.25 to 0.51, value < 0.001) based on a random effect model, with significant heterogeneity between studies (, , , , ). Figure 8 shows the forest plot of individual effect sizes within each study. Assessment for bias by Egger’s and Begg’s tests showed no significant small-study effects ( and , respectively). Further visual inspection of the funnel plot suggested a slight degree of publication bias (Figure 9).

(2) Sensitivity Analysis after Deleting the Studies with n=1. Removing these studies resulted in an effect size (95% CI: 0.11 to 0.25, value < 0.001), with a significant heterogeneity (, , , , ). Figure 10 shows the forest plot of individual effect sizes within each study.

(3) Subgroup Analysis of Diabetes in Recovered and Dead Pregnant and Postpartum Women. The forest plot of the individual effect size of predetermined subgroup analysis by dead/recovered is presented in Figure 11. The results indicate lower proportion of outcome in the recovered subgroup (, to 0.25), than in the dead subgroup (, to 0.25), so that the test showed a nonsignificant difference between the subgroups (, ). Additionally, the heterogeneity did not reduce in all subgroups ( and in the recovered and dead subgroups, respectively).

3.3.7. Meta-Analysis Results for Cardiovascular Diseases

(1) Cardiovascular Diseases in All Pregnant and Postpartum Women Affected by COVID-19. The proportion from 40 studies was 0.36 (95% CI: 0.24 to 0.48, value < 0.001) based on a random effect model, with significant heterogeneity between studies (, , , , ). Figure 12 shows the forest plot of individual effect sizes within each study. Assessment for bias by Egger’s and Begg’s tests showed no significant small-study effects ( and , respectively). Further visual inspection of the funnel plot suggested a slight degree of publication bias (Figure 13).

(2) Sensitivity Analysis after Deleting the Studies with n=1. Removing these studies resulted in an effect size (95% CI: 0.10 to 0.18, value < 0.001), with a significant heterogeneity (, , , , ). Figure 14 shows the forest plot of individual effect sizes within each study.

(3) Subgroup Analysis of Cardiovascular Diseases in Recovered and Dead Pregnant and Postpartum Women. The forest plot of the individual effect size of predetermined subgroup analysis by dead/recovered is presented in Figure 15. The results indicate lower proportion of outcome in the recovered subgroup (, to 0.18), than in the dead subgroup (, to 0.17), so that the test showed a nonsignificant difference between the subgroups (, ). Additionally, the heterogeneity did not reduce in all subgroup especially ( and I² = noncomputable in the recovered and dead subgroups, respectively).

3.3.8. Mode of Delivery in Pregnant and Postpartum Women Who Died of COVID-19

The mode of delivery in deceased cases with sufficient data () was as follows: 58.3% had cesarean section, 25% had vaginal delivery, and 16.7% were not full term. Meta-analysis for mode of delivery in the fatal cases showed that the proportion from 6 studies was 0.00 (95% CI: -0.03 to 0.04, value = 0.96) based on a random effect model, with nonsignificant heterogeneity between studies (, , , , ). Figure 16 shows the forest plot of individual effect sizes within each study.

Assessment for bias by Egger’s and Begg’s tests showed no significant small-study effects ( and , respectively). Further visual inspection of the funnel plot suggested a slight degree of publication bias (Figure 17).

3.3.9. Other Findings

Duration from admission to death was between 2 and 22 days [85, 124]. The most common complication during treatment of COVID-19 in pregnant and postpartum women was acute respiratory distress syndrome (ARDS). In fatal cases, PCR testing of the neonate was not indicated in 41.6% of cases (stillbirth, undelivered). In 41.6%, it was negative, and in 16.7% of the cases, the result of the initial test was negative and the second test was positive [124, 134].

4. Discussion

In this study, we systematically investigated 117 published reports involving 11758 pregnant women from the high- and middle-income countries assessing the effect of COVID-19 on the risk of mortality.

In this systematic review, the mortality rate of COVID-19 in pregnant and postpartum women was 1.30% and the rate of severe pneumonia was reported from 0 to 14%. The majority of the patients were admitted to the ICU, and the maternal death was consistent with reported outcomes from other severe viral lower respiratory tract infections [5, 135–140]. Unlike the current study, in some studies, the mortality rate of COVID-19-infected pregnant women was not higher than nonpregnant women of reproductive age [13, 58, 141]. The absence of deaths was explained by the younger age pregnant women who were infected because it has been shown that the mortality rate in COVID-19 patients is high in older individuals and those patients with at least one comorbidity [127]. Also, the number of cases in these studies was relatively small and all women were in their third trimester of pregnancy and most of them gave birth earlier than seven days after diagnosis of the disease. Hence, this clinical manifestation-to-delivery time may be too short to affect pregnancies [142]. Additionally, this discrepancy may be due to the data available at the time of publication in our study. The pregnancy-related immunological changes may be one of the causes of maternal vulnerability to COVID-19, but this did not significantly affect the response against SARS-CoV-2 [142]. In addition, maternal mortality rates were lower in high-income compared with low-income countries. In this systematic review, most of the studies were from China. It is possible that our study reported a higher mortality rate than other studies because our sample size was larger. Similar to this finding, it was shown that the incidence of maternal mortality rate in middle-income countries seems at least six times higher than that in high-income countries [142]. These findings indicate the weaknesses of maternity services in low-income countries. In addition, major barriers for a more equitable delivery of critical care in low-income countries may be an important factor, such that in Brazil—a middle-income country—only 72% of COVID-19-infected pregnant or postpartum women with COVID-19 were admitted to the ICU and 15% of them did not receive ventilation support [131]. In Mexico, only two out of seven deaths had been admitted to the ICU and received invasive respiratory assistance [143].

Viral pneumonia is one of the leading causes of pregnancy deaths worldwide [12]. The symptoms of pneumonia in pregnant women are not different from others [144]. Maternal deaths due to cardiopulmonary complications, sometimes with multiorgan failure, have been reported in the previous literatures [9, 31, 102, 145]. In one study, pregnant women with SARS-CoV-2 infection in their second or third trimester of pregnancy died due to cardiopulmonary complications [9].

In all of the fatal cases, fever alone or with cough, dyspnea, and myalgia were the most common symptoms, respectively. Sore throat and gastrointestinal symptoms were rare. In accordance with this finding in another systematic review, the most common symptoms at presentation were fever, cough, dyspnea/shortness of breath, fatigue, and myalgia [146]. Data from nonpregnant adults have described the most common presenting symptoms of COVID-19 as fever, cough, and dyspnea [147, 148]. In contrast with our review, in some other systematic reviews, the symptoms were significantly different with fever and cough occurring more than myalgia as well as dyspnea and fatigue occurring only in approximately one-sixth of symptomatic pregnant women [3, 149–153].

Another finding in this study was the high prevalence of maternal comorbidities. The comorbidity rate in deceased women was 20%, and most of the pregnant women show biochemical evidence of inflammation, mainly lymphopenia. However, in one study, nearly half of all patients (46%) had no baseline comorbidities [31]. In another study, approximately one out of every three women with SARS-CoV-2 infection had a comorbid condition, but no maternal deaths secondary to COVID-19 were reported [13]. High comorbidity and lack of maternal mortality may be due to the younger age of mothers. While similar to Khalil et al.’s study, maternal mortality in our study was higher due to advanced maternal age (35 years of age or older) [148] which makes management of comorbidities challenging. Also, these comorbidities per se could cause maternal deaths.

Advanced maternal age () was the most prevalent comorbidity; other comorbidities included diabetes, obesity, cardiovascular disease (essential hypertension, gestational hypertension, preeclampsia, HELLP syndrome, and heart problems), and history of asthma, respectively. These comorbidities suggest that maternal morbidity is not different from nonpregnant women of reproductive age. In one study, obesity and pulmonary conditions such as asthma and obstructive sleep apnea (OSA) were the most common comorbidities. Also, maternal ICU admission was one of the other outcomes. Also, pregnant and postpartum women with COVID-19 admitted to the ICUs are at risk for maternal death, which may occur even in the absence of substantial baseline comorbidities [31, 148]. Another comorbidity was antiviral drug use [146, 148]; while these two causes were not found in our study, the comorbidities could indirectly lead to patients’ ICU admission and administration of antiviral drugs. In contrast to our study, another study showed none of the pregnant patients had preexisting comorbidities, such as hypertension, cardiovascular disease, and asthma [9, 146].

Based on the results, the majority of deliveries in pregnant women with SARS COVID-19 were cesarean section. Similar to this result, COVID-19 infection was associated with a relatively higher cesarean delivery in other studies [10, 31, 146]. Also, in another systematic review, the rate of cesarean delivery was higher than in our study because more than 90% of cesarean sections were from China (306/332). Some articles from China have shown SARS-CoV-2 infection as an indication for cesarean delivery [154–156], thereby justifying such a difference in the rate of cesarean section. In contrast to this finding, in Ferrazzi et al.’s study, 57% of women delivered vaginally and elective cesarean sections were performed in 43% of cases. Dyspnea or other COVID-19-related symptoms resulted in 23.8% cesarean sections among COVID-19-infected patients [157]. In the study by Khalil et al., the rate of cesarean section in mothers with COVID-19 was less than in our study. This difference can be explained by the fact that in the study by Khalil et al., the rate of comorbidity was higher than our study (32.5% vs. 20%), and this issue could be the reason for the cesarean section rate reduction.

5. Limitation

There are no data available for the first and early second trimester of pregnancy infections. Other limitation is the retrospective design (especially reports and case series) of the study. Also, we have only included studies which are reported in the English language. The strengths of this study are large number of studies, relatively high sample size, and the inclusion of studies from different countries.

6. Conclusion

COVID-19 infection was associated with higher rates (and pooled proportions) of cesarean section in pregnant women and their mortality. Based on the results of this study, COVID-19 cannot be considered as an indication for caesarian delivery. Therefore, the timing and mode of delivery should be individualized based on obstetrical indication and maternal situation. The findings of this study can be a guide to prenatal enhanced counseling for pregnant women with COVID-19.

Data Availability

Data are available from the first and corresponding authors upon a reasonable request.

Conflicts of Interest

The authors report no conflict of interest.

Acknowledgments

Thanks are due for the financial support, guidance, and advice from the “Clinical Research Development Unit of Baqiyatallah Hospital.”

References

Q. Li, X. Guan, P. Wu et al., “Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia,” New England Journal of Medicine, vol. 382, no. 13, pp. 1199–1207, 2020.
View at: Publisher Site | Google Scholar
C. Huang, Y. Wang, X. Li et al., “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China,” The Lancet, vol. 395, no. 10223, pp. 497–506, 2020.
View at: Publisher Site | Google Scholar
D. Wang, B. Hu, C. Hu et al., “Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China,” JAMA, vol. 323, no. 11, pp. 1061–1069, 2020.
View at: Publisher Site | Google Scholar
A. Becker, “How does COVID-19 affect pregnancy and postpartum care?” June 2020, https://www.tmc.edu/news/2020/06/how-does-covid-19-affect-pregnancy-and-postpartum-care/.
View at: Google Scholar
F. Qadri and F. Mariona, “Pregnancy affected by SARS-CoV-2 infection: a flash report from Michigan,” The Journal of Maternal-Fetal & Neonatal Medicine, pp. 1–3, 2020.
View at: Publisher Site | Google Scholar
S. F. Wong, K. M. Chow, T. N. Leung et al., “Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome,” American Journal of Obstetrics and Gynecology, vol. 191, no. 1, pp. 292–297, 2004.
View at: Publisher Site | Google Scholar
T. G. Ksiazek, D. Erdman, C. S. Goldsmith et al., “A novel coronavirus associated with severe acute respiratory syndrome,” New England Journal of Medicine, vol. 348, no. 20, pp. 1953–1966, 2003.
View at: Publisher Site | Google Scholar
V. Vallejo and J. G. Ilagan, “A postpartum death due to coronavirus disease 2019 (COVID-19) in the United States,” Obstetrics & Gynecology, vol. 136, no. 1, pp. 52–55, 2020.
View at: Publisher Site | Google Scholar
S. Hantoushzadeh, A. A. Shamshirsaz, A. Aleyasin et al., “Maternal death due to COVID-19,” American Journal of Obstetrics and Gynecology, vol. 223, no. 1, pp. 109.e1–109.e16, 2020.
View at: Publisher Site | Google Scholar
D. Di Mascio, A. Khalil, G. Saccone et al., “Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis,” American Journal of Obstetrics & Gynecology MFM, vol. 2, no. 2, article 100107, 2020.
View at: Publisher Site | Google Scholar
R. C. Boelig, T. Manuck, E. A. Oliver et al., “Labor and delivery guidance for COVID-19,” American Journal of Obstetrics & Gynecology MFM, vol. 2, no. 2, 2020.
View at: Publisher Site | Google Scholar
S. Ellington, P. Strid, V. T. Tong et al., “Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22–June 7, 2020,” Morbidity and Mortality Weekly Report, vol. 69, no. 25, pp. 769–775, 2020.
View at: Publisher Site | Google Scholar
B. J. Huntley, E. S. Huntley, D. Di Mascio, T. Chen, V. Berghella, and S. P. Chauhan, “Rates of maternal and perinatal mortality and vertical transmission in pregnancies complicated by severe acute respiratory syndrome coronavirus 2 (SARS-Co-V-2) Infection,” Obstetrics & Gynecology, vol. 136, no. 2, pp. 303–312, 2020.
View at: Publisher Site | Google Scholar
H. Arksey and L. O'Malley, “Scoping studies: towards a methodological framework,” International Journal of social Research Methodology, vol. 8, no. 1, pp. 19–32, 2005.
View at: Publisher Site | Google Scholar
A. Liberati, D. G. Altman, J. Tetzlaff et al., “The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration,” Journal of Clinical Epidemiology, vol. 62, no. 10, pp. e1–e34, 2009.
View at: Publisher Site | Google Scholar
R. J. Hardy and S. G. Thompson, “A likelihood approach to meta-analysis with random effects,” Statistics in Medicine, vol. 15, no. 6, pp. 619–629, 1996.
View at: Publisher Site | Google Scholar
J. P. Higgins and S. G. Thompson, “Quantifying heterogeneity in a meta-analysis,” Statistics in Medicine, vol. 21, no. 11, pp. 1539–1558, 2002.
View at: Publisher Site | Google Scholar
M. Egger, G. D. Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” BMJ, vol. 315, no. 7109, pp. 629–634, 1997.
View at: Publisher Site | Google Scholar
C. B. Begg and M. Mazumdar, “Operating characteristics of a rank correlation test for publication bias,” Biometrics, vol. 50, no. 4, pp. 1088–1101, 1994.
View at: Publisher Site | Google Scholar
R. M. Harbord, M. Egger, and J. A. C. Sterne, “A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints,” Statistics in Medicine, vol. 25, no. 20, pp. 3443–3457, 2006.
View at: Publisher Site | Google Scholar
P. An, B. J. Wood, W. Li, M. Zhang, and Y. Ye, “Postpartum exacerbation of antenatal COVID-19 pneumonia in 3 women,” CMAJ, vol. 192, no. 22, pp. E603–E6E6, 2020.
View at: Google Scholar
J. Anderson, J. Schauer, S. Bryant, and C. R. Graves, “The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: a case report,” Case Reports in Women's Health, vol. 27, 2020.
View at: Publisher Site | Google Scholar
C. A. Blauvelt, C. Chiu, A. L. Donovan et al., “Acute respiratory distress syndrome in a preterm pregnant patient with coronavirus disease 2019 (COVID-19),” Obstetrics & Gynecology, vol. 136, no. 1, pp. 46–51, 2020.
View at: Publisher Site | Google Scholar
N. Breslin, C. Baptiste, C. Gyamfi-Bannerman et al., “Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals,” American Journal of Obstetrics & Gynecology MFM, vol. 2, no. 2, p. 100118, 2020.
View at: Publisher Site | Google Scholar
N. Breslin, C. Baptiste, R. Miller et al., “Coronavirus disease 2019 in pregnancy: early lessons,” American Journal of Obstetrics & Gynecology MFM, vol. 2, no. 2, p. 100111, 2020.
View at: Publisher Site | Google Scholar
P. C. Browne, J. B. Linfert, and E. Perez-Jorge, “Successful treatment of preterm labor in association with acute COVID-19 infection,” American Journal of Perinatology, vol. 37, no. 8, pp. 866–868, 2020.
View at: Publisher Site | Google Scholar
M. J. Fassett, L. D. Lurvey, L. Yasumura et al., “Universal SARS-Cov-2 screening in women admitted for delivery in a large managed care organization,” American Journal of Perinatology, vol. 37, no. 11, pp. 1110–1114, 2020.
View at: Publisher Site | Google Scholar
N. S. Fox and S. Melka, “COVID-19 in pregnant women: case series from one large New York City obstetrical practice,” American Journal of Perinatology, vol. 37, no. 10, pp. 1002–1004, 2020.
View at: Publisher Site | Google Scholar
I. Futterman, M. Toaff, L. Navi, and C. A. Clare, “Covid-19 and hellp: overlapping clinical pictures in two gravid patients,” American Journal of Perinatology Reports, vol. 10, no. 2, pp. E179–e182, 2020.
View at: Publisher Site | Google Scholar
I. T. Goldfarb, M. A. Clapp, M. D. Soffer et al., “Prevalence and severity of coronavirus disease 2019 (COVID-19) illness in symptomatic pregnant and postpartum women stratified by Hispanic ethnicity,” Obstetrics and Gynecology, vol. 136, no. 2, pp. 300–302, 2020.
View at: Publisher Site | Google Scholar
M. Gulersen, M. J. Blitz, B. Rochelson, M. Nimaroff, W. Shan, and E. Bornstein, “Clinical implications of SARS-CoV-2 infection in the viable preterm period,” American Journal of Perinatology, vol. 37, no. 11, pp. 1077–1083, 2020.
View at: Publisher Site | Google Scholar
A. Hirshberg, A. R. Kern-Goldberger, L. D. Levine et al., “Care of critically ill pregnant patients with coronavirus disease 2019: a case series,” American Journal of Obstetrics and Gynecology, vol. 223, no. 2, pp. 286–290, 2020.
View at: Publisher Site | Google Scholar
L. Hong, N. Smith, M. Keerthy et al., “Severe COVID-19 infection in pregnancy requiring intubation without preterm delivery: a case report,” Case Reports in Women's Health, vol. 27, p. e00217, 2020.
View at: Publisher Site | Google Scholar
S. N. Iqbal, R. Overcash, N. Mokhtari et al., “An uncomplicated delivery in a patient with Covid-19 in the United States,” New England Journal of Medicine, vol. 382, no. 16, p. e34, 2020.
View at: Publisher Site | Google Scholar
A. Juusela, M. Nazir, and M. Gimovsky, “Two cases of coronavirus 2019-related cardiomyopathy in pregnancy,” American Journal of Obstetrics & Gynecology MFM, vol. 3, no. 2, article 100113, 2020.
View at: Publisher Site | Google Scholar
J. C. Kelly, M. Dombrowksi, M. O'Neil-Callahan, A. S. Kernberg, A. I. Frolova, and M. J. Stout, “False-negative testing for severe acute respiratory syndrome coronavirus 2: consideration in obstetrical care,” American Journal of Obstetrics & Gynecology MFM, vol. 2, no. 3, article 100130, 2020.
View at: Publisher Site | Google Scholar
R. Khoury, P. S. Bernstein, C. Debolt et al., “Characteristics and outcomes of 241 births to women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at five New York City medical centers,” Obstetrics and Gynecology, vol. 136, no. 2, pp. 273–282, 2020, Epub 2020/06/20. eng.
View at: Publisher Site | Google Scholar
E. M. Lokken, C. L. Walker, S. Delaney et al., “Clinical characteristics of 46 pregnant women with a SARS-CoV-2 infection in Washington state,” American Journal of Obstetrics and Gynecology, vol. 223, no. 6, pp. 911.e1–911.e14, 2020, Epub 2020/05/23. eng.
View at: Publisher Site | Google Scholar
V. London, R. McLaren Jr., F. Atallah et al., “The relationship between status at presentation and outcomes among pregnant women with COVID-19,” American Journal of Perinatology, vol. 37, no. 10, pp. 991–994, 2020, Epub 2020/05/20. eng.
View at: Publisher Site | Google Scholar
E. Lucarelli, C. Behn, S. Lashley, D. Smok, C. Benito, and Y. Oyelese, “Mechanical ventilation in pregnancy due to COVID-19: a cohort of three cases,” American Journal of Perinatology, vol. 37, no. 10, pp. 1066–1069, 2020, Epub 2020/06/17. eng.
View at: Publisher Site | Google Scholar
H. Mehta, S. Ivanovic, A. Cronin, L. VanBrunt, and N. Mistry, “Novel coronavirus-related acute respiratory distress syndrome in a patient with twin pregnancy: a case report,” Case Reports in Women's Health, vol. 27, article e00220, 2020.
View at: Publisher Site | Google Scholar
J. J. Mulvey, C. M. Magro, L. X. Ma, G. J. Nuovo, and R. N. Baergen, “A mechanistic analysis placental intravascular thrombus formation in COVID-19 patients,” Annals of Diagnostic Pathology, vol. 46, p. 151529, 2020.
View at: Publisher Site | Google Scholar
M. Naqvi, P. Zakowski, L. Glucksman, S. Smithson, and R. M. Burwick, “Tocilizumab and remdesivir in a pregnant patient with coronavirus disease 2019 (COVID-19),” Obstetrics and Gynecology, vol. 136, no. 5, pp. 1025–1029, 2020, Epub 2020/07/04. eng.
View at: Publisher Site | Google Scholar
P.-W. RAM, J. Burd, L. Felder et al., “Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study,” American Journal of Obstetrics & Gynecology MFM, vol. 2, no. 3, article 100134, 2020.
View at: Publisher Site | Google Scholar
M. Prabhu, K. Cagino, K. C. Matthews et al., “Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study,” BJOG : An International Journal of Obstetrics and Gynaecology, vol. 127, no. 12, pp. 1548–1556, 2020, Epub 2020/07/08. eng.
View at: Publisher Site | Google Scholar
S. R. Rabice, P. C. Altshuler, C. Bovet, C. Sullivan, and A. J. Gagnon, “COVID-19 infection presenting as pancreatitis in a pregnant woman: a case report,” Case Reports in Women's Health, vol. 27, article e00228, 2020.
View at: Publisher Site | Google Scholar
E. S. Rubin, S. A. Sansone, A. Hirshberg, E. G. Clement, and S. K. Srinivas, “Detection of COVID-19 in a vulvar lesion,” American Journal of Perinatology, vol. 37, no. 11, pp. 1183-1184, 2020, Epub 2020/07/03. eng.
View at: Publisher Site | Google Scholar
W. T. Schnettler, Y. Al Ahwel, and A. Suhag, “Severe acute respiratory distress syndrome in coronavirus disease 2019-infected pregnancy: obstetric and intensive care considerations,” American Journal of Obstetrics & Gynecology MFM, vol. 2, no. 3, article 100120, 2020.
View at: Publisher Site | Google Scholar
J. S. Silverstein, M. A. Limaye, S. G. Brubaker et al., “Acute respiratory decompensation requiring intubation in pregnant women with SARS-CoV-2 (COVID-19),” American Journal of Perinatology Reports, vol. 10, no. 2, pp. E169–e175, 2020, English.
View at: Publisher Site | Google Scholar
R. G. Sinkey, I. Rajapreyar, L. S. Robbins et al., “Heart failure with preserved ejection fraction in a postpartum patient with superimposed preeclampsia and COVID-19,” American Journal of Perinatology Reports, vol. 10, no. 2, pp. E165–e168, 2020, English.
View at: Publisher Site | Google Scholar
S. Slayton-Milam, S. Sheffels, D. Chan, and B. Alkinj, “Induction of labor in an intubated patient with coronavirus disease 2019 (COVID-19),” Obstetrics and Gynecology, vol. 136, no. 5, pp. 962–964, 2020, Epub 2020/06/27. eng.
View at: Publisher Site | Google Scholar
L. Barile, M. Cerrano, A. Locatelli, A. Puppo, A. F. Signorile, and N. Barzaghi, “Prone ventilation in a 27 week pregnant woman with COVID-19 severe ards,” Signa Vitae, vol. 16, no. 1, pp. 199–202, 2020.
View at: Google Scholar
D. Buonsenso, F. Raffaelli, E. Tamburrini et al., “Clinical role of lung ultrasound for diagnosis and monitoring of COVID-19 pneumonia in pregnant women,” Ultrasound in Obstetrics & Gynecology, vol. 56, no. 1, pp. 106–109, 2020.
View at: Publisher Site | Google Scholar
A. Carosso, S. Cosma, F. Borella et al., “Pre-labor anorectal swab for SARS-CoV-2 in COVID-19 pregnant patients: is it time to think about it?” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 249, pp. 98-99, 2020, English.
View at: Publisher Site | Google Scholar
G. V. De Socio, L. Malincarne, S. Arena et al., “Delivery in asymptomatic Italian woman with SARS-CoV-2 infection,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 12, no. 1, article e2020033, 2020.
View at: Publisher Site | Google Scholar
A. De Castro, M. Abu-Hishmeh, I. El Husseini, and L. Paul, “Haemophilus parainfluenzae endocarditis with multiple cerebral emboli in a pregnant woman with coronavirus,” IDCases, vol. 18, article e00593, 2019.
View at: Publisher Site | Google Scholar
A. Ferraiolo, F. Barra, C. Kratochwila et al., “Report of positive placental swabs for sars-cov-2 in an asymptomatic pregnant woman with covid-19,” Medicina, vol. 56, no. 6, p. 306, 2020.
View at: Publisher Site | Google Scholar
I. Martinelli, E. Ferrazzi, A. Ciavarella et al., “Pulmonary embolism in a young pregnant woman with COVID-19,” Thrombosis Research, vol. 191, pp. 36-37, 2020, English.
View at: Publisher Site | Google Scholar
V. M. Savasi, F. Parisi, L. Patanè et al., “Clinical findings and disease severity in hospitalized pregnant women with coronavirus disease 2019 (COVID-19),” Obstetrics and Gynecology, vol. 136, no. 2, pp. 252–258, 2020, Epub 2020/05/21. eng.
View at: Publisher Site | Google Scholar
I. Ahmed, A. Azhar, N. Eltaweel, and B. K. Tan, “First COVID‐19 maternal mortality in the UK associated with thrombotic complications,” British Journal of Haematology, vol. 190, no. 1, pp. e37–e38, 2020, English.
View at: Publisher Site | Google Scholar
D. Baud, G. Greub, G. Favre et al., “Second-trimester miscarriage in a pregnant woman with SARS-CoV-2 infection,” JAMA - Journal of the American Medical Association, vol. 323, no. 21, pp. 2198–2200, 2020, English.
View at: Publisher Site | Google Scholar
J. Cohen, O. Vignaux, and F. Jacquemard, “Covid-19 in pregnant women: general data from a French National Survey,” European Journal of Obstetrics, Gynecology, and Reproductive Biology, vol. 251, pp. 267-268, 2020.
View at: Publisher Site | Google Scholar
J. Collin, E. Byström, A. Carnahan, and M. Ahrne, “Public Health Agency of Sweden’s brief report: pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden,” Acta Obstetricia et Gynecologica Scandinavica, vol. 99, no. 7, pp. 819–822, 2020, English.
View at: Publisher Site | Google Scholar
W. R. Cooke, A. Billett, S. Gleeson et al., “SARS-CoV-2 infection in very preterm pregnancy: experiences from two cases,” European Journal of Obstetrics, Gynecology, and Reproductive Biology, vol. 250, pp. 259-260, 2020.
View at: Publisher Site | Google Scholar
M. Dória, C. Peixinho, M. Laranjo, A. Mesquita Varejão, and P. T. Silva, “Covid-19 during pregnancy: a case series from an universally tested population from the north of Portugal,” European Journal of Obstetrics, Gynecology, and Reproductive Biology, vol. 250, no. 10, pp. 261-262, 2020.
View at: Publisher Site | Google Scholar
F. Fontanella, S. Hannes, N. Keating et al., “COVID-19 infection during the third trimester of pregnancy: current clinical dilemmas,” European Journal of Obstetrics, Gynecology, and Reproductive Biology, vol. 251, pp. 268–271, 2020, English.
View at: Publisher Site | Google Scholar
S. Gidlöf, J. Savchenko, T. Brune, and H. Josefsson, “COVID-19 in pregnancy with comorbidities: more liberal testing strategy is needed,” Acta Obstetricia et Gynecologica Scandinavica, vol. 99, no. 7, pp. 948-949, 2020.
View at: Publisher Site | Google Scholar
D. González Romero, J. Ocampo Pérez, L. González Bautista, and L. Santana-Cabrera, “Pregnancy and perinatal outcome of a woman with COVID-19 infection,” Revista Clínica Española, vol. 220, no. 8, pp. 533-534, 2020.
View at: Publisher Site | Google Scholar
A. Govind, S. Essien, A. Karthikeyan et al., “Re: Novel coronavirus COVID-19 in late pregnancy: outcomes of first nine cases in an inner city London hospital,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 251, pp. 272–274, 2020.
View at: Publisher Site | Google Scholar
K. Grimminck, L. A. M. Santegoets, F. C. Siemens, P. L. A. Fraaij, I. K. M. Reiss, and S. Schoenmakers, “No evidence of vertical transmission of SARS-CoV-2 after induction of labour in an immune-suppressed SARS-CoV-2-positive patient,” BMJ Case Reports, vol. 13, no. 6, article e235581, 2020, Epub 2020/07/02. eng.
View at: Publisher Site | Google Scholar
G. Kayem, E. Lecarpentier, P. Deruelle et al., “A snapshot of the Covid-19 pandemic among pregnant women in France,” Journal of Gynecology Obstetrics and Human Reproduction, vol. 49, no. 7, article 101826, 2020.
View at: Publisher Site | Google Scholar
K. Kuhrt, J. McMicking, S. Nanda, C. Nelson-Piercy, and A. Shennan, “Placental abruption in a twin pregnancy at 32 weeks’ gestation complicated by COVID-19, without vertical transmission to the babies,” American Journal of Obstetrics & Gynecology MFM, vol. 2, no. 3, article 100135, 2020.
View at: Publisher Site | Google Scholar
B. Lowe and B. Bopp, “COVID-19 vaginal delivery – a case report,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 60, no. 3, pp. 465-466, 2020.
View at: Publisher Site | Google Scholar
J. Lyra, R. Valente, M. Rosário, and M. Guimarães, “Cesarean section in a pregnant woman with COVID-19: first case in Portugal,” Acta Médica Portuguesa, vol. 33, no. 6, article 13883, pp. 429–431, 2020.
View at: Publisher Site | Google Scholar
O. Martínez-Perez, M. Vouga, S. Cruz Melguizo et al., “Association between mode of delivery among pregnant women with COVID-19 and maternal and neonatal outcomes in Spain,” JAMA - Journal of the American Medical Association, vol. 324, no. 3, pp. 296–299, 2020, English.
View at: Publisher Site | Google Scholar
M. Mendoza, I. Garcia-Ruiz, N. Maiz et al., “Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 127, no. 11, pp. 1374–1380, 2020.
View at: Publisher Site | Google Scholar
G. Nesr, C. Garnett, C. Bailey, and S. Arami, “Immune thrombocytopenia flare with mild COVID-19 infection in pregnancy: a case report,” British Journal of Haematology, vol. 190, no. 3, pp. e146–e148, 2020.
View at: Publisher Site | Google Scholar
A. Pereira, S. Cruz-Melguizo, M. Adrien, L. Fuentes, E. Marin, and T. Perez-Medina, “Clinical course of coronavirus disease-2019 in pregnancy,” Acta Obstetricia et Gynecologica Scandinavica, vol. 99, no. 7, pp. 839–847, 2020, English.
View at: Publisher Site | Google Scholar
R. San-Juan, P. Barbero, M. Fernández-Ruiz et al., “Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: a single-centre cohort study from Spain,” EClinicalMedicine, vol. 23, p. 100407, 2020, English.
View at: Publisher Site | Google Scholar
L. Sentilhes, F. De Marcillac, C. Jouffrieau et al., “COVID-19 in pregnancy was associated with maternal morbidity and preterm birth,” American Journal of Obstetrics and Gynecology, vol. 223, no. 6, pp. 914.e1–914.e15, 2020.
View at: Publisher Site | Google Scholar
F. Vibert, M. Kretz, V. Thuet et al., “Prone positioning and high-flow oxygen improved respiratory function in a 25-week pregnant woman with COVID-19,” European Journal of Obstetrics, Gynecology, and Reproductive Biology, vol. 250, pp. 257-258, 2020.
View at: Publisher Site | Google Scholar
A. J. Vivanti, J. Mattern, C. Vauloup-Fellous et al., “Retrospective description of pregnant women infected with severe acute respiratory syndrome coronavirus 2, France,” Emerging Infectious Diseases, vol. 26, no. 9, pp. 2069–2076, 2020.
View at: Publisher Site | Google Scholar
M. Kirtsman, Y. Diambomba, S. M. Poutanen et al., “Probable congenital sars-cov-2 infection in a neonate born to a woman with active sars-cov-2 infection,” CMAJ, vol. 192, no. 24, pp. E647–E650, 2020, English.
View at: Publisher Site | Google Scholar
H. Al-Kuraishy, T. Al-Maiahy, A. Al-Gareeb, R. Musa, and Z. Ali, “COVID-19 pneumonia in an Iraqi pregnant woman with preterm delivery,” Asian Pacific Journal of Reproduction, vol. 9, no. 3, pp. 156–158, 2020.
View at: Google Scholar
L. A. AlZaghal, N. AlZaghal, S. O. Alomari, N. Obeidat, B. Obeidat, and W. A. Hayajneh, “Multidisciplinary team management and cesarean delivery for a Jordanian woman infected with SARS-COV-2: a case report,” Case Reports in Women's Health, vol. 27, article e00212, 2020.
View at: Publisher Site | Google Scholar
M. C. Alzamora, T. Paredes, D. Caceres, C. M. Webb, L. M. Valdez, and M. La Rosa, “Severe COVID-19 during pregnancy and possible vertical transmission,” American Journal of Perinatology, vol. 37, no. 8, pp. 861–865, 2020.
View at: Publisher Site | Google Scholar
D. A. Bani Hani, I. Alsharaydeh, A. M. Bataineh et al., “Successful anesthetic management in cesarean section for pregnant woman with COVID-19,” The American Journal of Case Reports, vol. 21, article e925512, 2020.
View at: Publisher Site | Google Scholar
A. Bastug, A. Hanifehnezhad, C. Tayman et al., “Virolactia in an asymptomatic mother with COVID-19,” Breastfeeding Medicine, vol. 15, no. 8, pp. 488–491, 2020.
View at: Publisher Site | Google Scholar
D. Cao, H. Yin, J. Chen et al., “Clinical analysis of ten pregnant women with COVID-19 in Wuhan, China: a retrospective study,” International Journal of Infectious Diseases, vol. 95, pp. 294–300, 2020.
View at: Publisher Site | Google Scholar
H. J. Chen, J. J. Guo, C. Wang et al., “Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records,” The Lancet, vol. 395, no. 10226, pp. 809–815, 2020.
View at: Publisher Site | Google Scholar
L. Chen, Q. Li, D. Zheng et al., “Clinical characteristics of pregnant women with Covid-19 in Wuhan, China,” New England Journal of Medicine, vol. 382, no. 25, p. e100, 2020.
View at: Publisher Site | Google Scholar
R. Chen, Y. Zhang, L. Huang, B. H. Cheng, Z. Y. Xia, and Q. T. Meng, “Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing cesarean delivery: a case series of 17 patients,” Canadian Journal of Anesthesia, vol. 67, no. 6, pp. 655–663, 2020, English.
View at: Publisher Site | Google Scholar
S. Chen, E. Liao, D. Cao, Y. Gao, G. Sun, and Y. Shao, “Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia,” Journal of Medical Virology, vol. 92, no. 9, pp. 1556–1561, 2020.
View at: Publisher Site | Google Scholar
Y. Chen, H. Peng, L. Wang et al., “Infants born to mothers with a new coronavirus (COVID-19),” Frontiers in Pediatrics, vol. 8, p. 104, 2020.
View at: Publisher Site | Google Scholar
A. Chhabra, T. Rao, M. Kumar, Y. Singh, and R. Subramaniam, “Anaesthetic management of a COVID-19 parturient for caesarean section - case report and lessons learnt,” Indian Journal of Anaesthesia, vol. 64, no. 14, pp. S141–S143, 2020.
View at: Publisher Site | Google Scholar
Y. Du, L. Wang, G. Wu, X. M. Lei, W. Li, and J. R. Lv, “Anesthesia and protection in an emergency cesarean section for pregnant woman infected with a novel coronavirus: case report and literature review,” Journal of Anesthesia, vol. 34, no. 4, pp. 613–618, 2020.
View at: Publisher Site | Google Scholar
C. Fan, D. Lei, C. Fang et al., “Perinatal transmission of COVID-19 associated SARS-CoV-2: should we worry?” Clinical Infectious Diseases, vol. 17, article ciaa226, 2020.
View at: Publisher Site | Google Scholar
D. A. Forero-Peña, M. I. Rodríguez, D. M. Flora-Noda et al., “The first pregnant woman with COVID-19 in Venezuela: pre-symptomatic transmission,” Travel Medicine and Infectious Disease, vol. 25, article 101805, 2020.
View at: Publisher Site | Google Scholar
S. Hantoushzadeh, A. A. Shamshirsaz, A. Aleyasin et al., “Maternal death due to COVID-19 disease,” American Journal of Obstetrics and Gynecology, vol. 223, no. 1, pp. 109.e1–109.e16, 2020.
View at: Publisher Site | Google Scholar
W. Huang, Z. Zhao, Z. He et al., “Unfavorable outcomes in pregnant patients with COVID-19 outside Wuhan, China,” Journal of Infection, vol. 81, no. 2, pp. e99–e101, 2020.
View at: Publisher Site | Google Scholar
E. Kalafat, E. Yaprak, G. Cinar et al., “Lung ultrasound and computed tomographic findings in pregnant woman with COVID-19,” Ultrasound in Obstetrics & Gynecology, vol. 55, no. 6, pp. 835–837, 2020.
View at: Publisher Site | Google Scholar
P. Karami, M. Naghavi, A. Feyzi et al., “Mortality of a pregnant patient diagnosed with COVID-19: a case report with clinical, radiological, and histopathological findings,” Travel Medicine and Infectious Disease, no. article 101665, 2020.
View at: Publisher Site | Google Scholar
S. Khan, L. Y. Peng, R. Siddique et al., “Impact of COVID-19 infection on pregnancy outcomes and the risk of maternal-to-neonatal intrapartum transmission of COVID-19 during natural birth,” Infection Control & Hospital Epidemiology, vol. 41, no. 6, pp. 748–750, 2020.
View at: Publisher Site | Google Scholar
G. J. Lang and H. Zhao, “Can SARS-CoV-2-infected women breastfeed after viral clearance?” Journal of Zhejiang University. Science. B, vol. 21, no. 5, pp. 405–407, 2020.
View at: Publisher Site | Google Scholar
N. Li, L. Han, M. Peng et al., “Maternal and neonatal outcomes of pregnant women with Coronavirus Disease 2019 (COVID-19) pneumonia: a case-control study,” Clinical Infectious Diseases, vol. 71, no. 16, pp. 2035–2041, 2020.
View at: Publisher Site | Google Scholar
G. Capobianco, L. Saderi, S. Aliberti et al., “COVID-19 in pregnant women: a systematic review and meta-analysis,” European Journal of Obstetrics, Gynecology, and Reproductive Biology, vol. 252, pp. 543–558, 2020.
View at: Publisher Site | Google Scholar
X. G. Liao, H. Yang, J. F. Kong, and H. B. Yang, “Chest CT findings in a pregnant patient with 2019 novel coronavirus disease,” Balkan Medical Journal, vol. 37, no. 4, pp. 226–228, 2020.
View at: Publisher Site | Google Scholar
D. Liu, L. Li, X. Wu et al., “Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis,” AJR. American Journal of Roentgenology, vol. 215, pp. W17–W18, 2020.
View at: Publisher Site | Google Scholar
H. H. Liu, F. Liu, J. N. Li, T. T. Zhang, D. B. Wang, and W. S. Lan, “Clinical and CT imaging features of the COVID-19 pneumonia: focus on pregnant women and children,” Journal of Infection, vol. 80, no. 5, pp. E7–E13, 2020.
View at: Publisher Site | Google Scholar
Y. Liu, H. Chen, K. Tang, and Y. Guo, “Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy,” The Journal of Infection, vol. 4, 2020.
View at: Publisher Site | Google Scholar
D. W. Lu, L. Sang, S. H. Du, T. Li, Y. G. Chang, and X. A. Yang, “Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission,” Journal of Medical Virology, vol. 92, no. 9, pp. 1660–1664, 2020.
View at: Publisher Site | Google Scholar
P. Panichaya, W. Thaweerat, and J. Uthaisan, “Prolonged viral persistence in COVID-19 second trimester pregnant patient,” European Journal of Obstetrics, Gynecology, and Reproductive Biology, vol. 50, p. 263, 2020.
View at: Publisher Site | Google Scholar
Z. Peng, J. Wang, Y. Mo et al., “Unlikely SARS-CoV-2 vertical transmission from mother to child: a case report,” Journal of Infection and Public Health, vol. 13, no. 5, pp. 818–820, 2020.
View at: Publisher Site | Google Scholar
X. Qiancheng, S. Jian, P. Lingling et al., “Coronavirus disease 2019 in pregnancy,” International Journal of Infectious Diseases, vol. 95, pp. 376–383, 2020.
View at: Publisher Site | Google Scholar
S. Shojaei, M. Kouchek, M. M. Miri et al., “Twin pregnant woman with COVID-19: a case report,” Journal of Cellular & Molecular Anesthesia, vol. 5, no. 1, pp. 43–46, 2020.
View at: Google Scholar
A. Taghizadieh, H. Mikaeili, M. Ahmadi, and H. Valizadeh, “Acute kidney injury in pregnant women following SARS-CoV-2 infection: a case report from Iran,” Respiratory Medicine Case Reports, vol. 30, p. 101090, 2020.
View at: Publisher Site | Google Scholar
M. L. S. Takemoto, M. O. Menezes, C. B. Andreucci et al., “The tragedy of COVID-19 in Brazil: 124 maternal deaths and counting,” International Journal of Gynaecology and Obstetrics, vol. 151, no. 1, pp. 154–156, 2020.
View at: Publisher Site | Google Scholar
C. T. Tutiya, M. M. Siaulys, M. M. Kondo et al., “Possible formation of pulmonary microthrombi in the early puerperium of pregnant women critically ill with COVID-19: two case reports,” Case Reports in Women's Health, vol. 27, article e00237, 2020.
View at: Publisher Site | Google Scholar
X. Wang, Z. Zhou, J. Zhang, F. Zhu, Y. Tang, and X. Shen, “A case of 2019 Novel coronavirus in a pregnant woman with preterm delivery,” Clinical Infectious Diseases, vol. 71, no. 15, pp. 844–846, 2020.
View at: Publisher Site | Google Scholar
Z. Wang, Z. Wang, and G. Xiong, “Clinical characteristics and laboratory results of pregnant women with COVID-19 in Wuhan, China,” International Journal of Gynecology & Obstetrics, vol. 150, no. 3, pp. 312–317, 2020.
View at: Publisher Site | Google Scholar
C. Wu, W. Yang, X. Wu et al., “Clinical manifestation and laboratory characteristics of SARS-CoV-2 infection in pregnant women,” Virologica Sinica, vol. 35, no. 3, pp. 305–310, 2020.
View at: Publisher Site | Google Scholar
X. Q. Wu, R. H. Sun, J. P. Chen, Y. L. Xie, S. T. Zhang, and X. Wang, “Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia,” International Journal of Gynecology & Obstetrics, vol. 150, no. 1, pp. 58–63, 2020.
View at: Publisher Site | Google Scholar
Y. Wu, C. Liu, L. Dong et al., “Coronavirus disease 2019 among pregnant Chinese women: case series data on the safety of vaginal birth and breastfeeding,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 127, no. 9, pp. 1109–1115, 2020.
View at: Publisher Site | Google Scholar
H. Xia, S. Zhao, Z. Wu, H. Luo, C. Zhou, and X. Chen, “Emergency caesarean delivery in a patient with confirmed COVID-19 under spinal anaesthesia,” British Journal of Anaesthesia, vol. 124, no. 5, pp. e216–e218, 2020.
View at: Publisher Site | Google Scholar
X. Xiong, H. Wei, Z. Zhang et al., “Vaginal delivery report of a healthy neonate born to a convalescent mother with COVID‐19,” Journal of Medical Virology, vol. 92, no. 9, pp. 1657–1659, 2020, English.
View at: Publisher Site | Google Scholar
L. Xu, Q. Yang, H. Shi et al., “Clinical presentations and outcomes of SARS-CoV-2 infected pneumonia in pregnant women and health status of their neonates,” Scientific Bulletin, vol. 65, no. 18, pp. 1537–1542, 2020.
View at: Publisher Site | Google Scholar
J. Yan, J. Guo, C. Fan et al., “Coronavirus disease 2019 (COVID-19) in pregnant women: a report based on 116 cases,” American Journal of Obstetrics and Gynecology, vol. 23, no. 20, p. 30462, 2020.
View at: Google Scholar
H. Yang, B. Hu, S. Zhan, L. Y. Yang, and G. Xiong, “Effects of SARS-CoV-2 infection on pregnant women and their infants: a retrospective study in Wuhan, China,” Archives of Pathology & Laboratory Medicine, vol. 18, no. 10, p. 2020, 2020.
View at: Google Scholar
M. Yassa, P. Birol, A. M. Mutlu, A. B. Tekin, K. Sandal, and N. Tug, “Lung ultrasound can influence the clinical treatment of pregnant women with COVID-19,” Journal of Ultrasound in Medicine, vol. 1, 2020.
View at: Google Scholar
N. Yu, W. Li, Q. Kang et al., “Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study,” The Lancet Infectious Diseases, vol. 20, no. 5, pp. 559–564, 2020.
View at: Publisher Site | Google Scholar
M. Zamaniyan, A. Ebadi, S. Aghajanpoor, Z. Rahmani, M. Haghshenas, and S. Azizi, “Preterm delivery, maternal death, and vertical transmission in a pregnant woman with COVID-19 infection,” Prenatal Diagnosis, vol. 40, no. 13, pp. 1759–1761, 2020.
View at: Publisher Site | Google Scholar
L. I. Zambrano, I. C. Fuentes-Barahona, D. A. Bejarano-Torres et al., “A pregnant woman with COVID-19 in Central America,” Travel Medicine and Infectious Disease, vol. 36, article 101639, 2020.
View at: Publisher Site | Google Scholar
Y. Zeng, L. Lin, Q. Yan et al., “Update on clinical outcomes of women with COVID-19 during pregnancy,” International Journal of Gynecology & Obstetrics, vol. 150, no. 2, pp. 264–266, 2020.
View at: Publisher Site | Google Scholar
L. Zhang, L. Dong, L. Ming et al., “Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection during late pregnancy: a report of 18 patients from Wuhan, China,” BMC Pregnancy and Childbirth, vol. 20, no. 1, pp. 1–7, 2020.
View at: Google Scholar
S. Rasmussen, D. Jamieson, and T. Uyeki, “Effects of influenza on pregnant women and infants,” Obstetric Anesthesia Digest, vol. 33, no. 4, pp. 208-209, 2013.
View at: Publisher Site | Google Scholar
H. Alserehi, G. Wali, A. Alshukairi, and B. Alraddadi, “Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome,” BMC Infectious Diseases, vol. 16, no. 1, pp. 1–4, 2016.
View at: Google Scholar
K. Aagaard-Tillery, R. Silver, and J. Dalton, “Normal pregnancy,” Seminars in Fetal & Neonatal Medicine, vol. 11, pp. 279–295, 2006, Immunology of the Female Genital Tract. 2002;8:12.
View at: Google Scholar
E. Q. Littauer and I. Skountzou, “Hormonal regulation of physiology, innate immunity and antibody response to H1N1 influenza virus infection during pregnancy,” Frontiers in Immunology, vol. 9, p. 2455, 2018.
View at: Publisher Site | Google Scholar
L. G. Mosby, S. A. Rasmussen, and D. J. Jamieson, “2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature,” American Journal of Obstetrics and Gynecology, vol. 205, no. 1, pp. 10–18, 2011.
View at: Publisher Site | Google Scholar
V. Berghella, “Coronavirus disease 2019 (COVID-19): pregnancy issues,” 2020, UpToDate Internet, last updated: Feb 15, 2021.
View at: Google Scholar
S. Muhidin, Z. B. Moghadam, and M. Vizheh, “Analysis of maternal coronavirus infections and neonates born to mothers with 2019-nCoV; a systematic review,” Archives of Academic Emergency Medicine, vol. 8, no. 1, 2020.
View at: Google Scholar
M. O. Menezes, M. L. S. Takemoto, M. Nakamura‐Pereira et al., “Risk factors for adverse outcomes among pregnant and postpartum women with acute respiratory distress syndrome due to COVID-19 in Brazil,” International Journal of Gynecology & Obstetrics, vol. 151, no. 3, pp. 415–423, 2020.
View at: Publisher Site | Google Scholar
M. I. Lumbreras‐Marquez, M. Campos‐Zamora, H. Lizaola‐Diaz de Leon, and M. K. Farber, “Maternal mortality from COVID-19 in Mexico,” International Journal of Gynecology & Obstetrics, vol. 150, no. 2, pp. 266-267, 2020.
View at: Publisher Site | Google Scholar
L. Panahi, M. Amiri, and S. Pouy, “Risks of novel coronavirus disease (COVID-19) in pregnancy; a narrative review,” Archives of Academic Emergency Medicine, vol. 8, no. 1, 2020.
View at: Google Scholar
M. Knight, K. Bunch, N. Vousden et al., “Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study,” BMJ, vol. 369, 2020.
View at: Publisher Site | Google Scholar
J. Juan, M. Gil, Z. Rong, Y. Zhang, H. Yang, and L. Poon, “Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review,” Ultrasound in Obstetrics & Gynecology, vol. 56, no. 1, pp. 15–27, 2020.
View at: Publisher Site | Google Scholar
W. J. Guan, Z. Y. Ni, Y. Hu et al., “Clinical characteristics of coronavirus disease 2019 in China,” New England Journal of Medicine, vol. 382, no. 18, pp. 1708–1720, 2020.
View at: Publisher Site | Google Scholar
A. Khalil, E. Kalafat, C. Benlioglu et al., “SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis of clinical features and pregnancy outcomes,” EClinicalMedicine, vol. 25, article 100446, 2020.
View at: Publisher Site | Google Scholar
M. Cao, D. Zhang, Y. Wang et al., Clinical features of patients infected with the 2019 novel coronavirus (COVID-19) in Shanghai, China, MedRxiv, 2020.
F. Parazzini, R. Bortolus, P. A. Mauri, A. Favilli, S. Gerli, and E. Ferrazzi, “Delivery in pregnant women infected with SARS-CoV-2: A fast review,” International Journal of Gynecology & Obstetrics, vol. 150, no. 1, pp. 41–46, 2020.
View at: Publisher Site | Google Scholar
R. Wen, Y. Sun, and Q.-S. Xing, “A patient with SARS-CoV-2 infection during pregnancy in Qingdao, China,” Journal of Microbiology, Immunology and Infection, vol. 53, no. 3, pp. 499-500, 2020.
View at: Publisher Site | Google Scholar
L. Dong, J. Tian, S. He et al., “Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn,” Journal of the American Medical Association, vol. 323, no. 18, pp. 1846–1848, 2020.
View at: Publisher Site | Google Scholar
H. Zeng, C. Xu, J. Fan et al., “Antibodies in infants born to mothers with COVID-19 pneumonia,” Journal of the American Medical Association, vol. 323, no. 18, pp. 1848-1849, 2020.
View at: Publisher Site | Google Scholar
M. H. Murad, S. Sultan, S. Haffar, and F. Bazerbachi, “Methodological quality and synthesis of case series and case reports,” BMJ Evidence-Based Medicine, vol. 23, no. 2, pp. 60–63, 2018.
View at: Publisher Site | Google Scholar
H. Zhu, L. Wang, C. Fang et al., “Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia,” Translational Pediatrics, vol. 9, no. 1, pp. 51–60, 2020.
View at: Publisher Site | Google Scholar
J. Liu, X. Liao, S. Qian et al., “Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020,” Emerging Infectious Diseases, vol. 26, no. 6, pp. 1320–1323, 2020.
View at: Publisher Site | Google Scholar
E. Ferrazzi, L. Frigerio, V. Savasi et al., “Mode of delivery and clinical findings in COVID-19 infected pregnant women in Northern Italy,” SSRN Electronic Journal, 2020.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2021 Leila Karimi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

5932

Downloads

3353

Citations